These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 29068268)

  • 1. Structural insights into the binding mode of flavonols with the active site of matrix metalloproteinase-9 through molecular docking and molecular dynamic simulations studies.
    Pradiba D; Aarthy M; Shunmugapriya V; Singh SK; Vasanthi M
    J Biomol Struct Dyn; 2018 Nov; 36(14):3718-3739. PubMed ID: 29068268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent inhibitors precise to S1' loop of MMP-13, a crucial target for osteoarthritis.
    Kalva S; Saranyah K; Suganya PR; Nisha M; Saleena LM
    J Mol Graph Model; 2013 Jul; 44():297-310. PubMed ID: 23938376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.
    Jana S; Singh SK
    J Biomol Struct Dyn; 2019 Mar; 37(4):944-965. PubMed ID: 29475408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for the selective inhibitors of MMP-9 from natural products based on pharmacophore modeling and molecular docking in combination with bioassay experiment, hybrid QM/MM calculation, and MD simulation.
    Hou J; Zou Q; Wang Y; Gao Q; Yao W; Yao Q; Zhang J
    J Biomol Struct Dyn; 2019 Aug; 37(12):3135-3149. PubMed ID: 30079817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational and In Vitro Investigation of (-)-Epicatechin and Proanthocyanidin B2 as Inhibitors of Human Matrix Metalloproteinase 1.
    Lee KE; Bharadwaj S; Yadava U; Kang SG
    Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32998374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
    Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
    J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated computational and experimental approach to gaining selectivity for MMP-2 within the gelatinase subfamily.
    Fabre B; Filipiak K; Díaz N; Zapico JM; Suárez D; Ramos A; de Pascual-Teresa B
    Chembiochem; 2014 Feb; 15(3):399-412. PubMed ID: 24449516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple receptor-ligand based pharmacophore modeling and molecular docking to screen the selective inhibitors of matrix metalloproteinase-9 from natural products.
    Gao Q; Wang Y; Hou J; Yao Q; Zhang J
    J Comput Aided Mol Des; 2017 Jul; 31(7):625-641. PubMed ID: 28623487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping intermolecular interactions and active site conformations: from human MMP-1 crystal structure to molecular dynamics free energy calculations.
    Nash A; Birch HL; de Leeuw NH
    J Biomol Struct Dyn; 2017 Feb; 35(3):564-573. PubMed ID: 26886688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design of hERG-neutral antihypertensive oxazalone and imidazolone derivatives.
    Aksoydan B; Kantarcioglu I; Erol I; Salmas RE; Durdagi S
    J Mol Graph Model; 2018 Jan; 79():103-117. PubMed ID: 29156380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel selective MMP-9 inhibitors as potential anti-metastatic lead using structure-based hierarchical virtual screening and molecular dynamics simulation.
    Kalva S; Agrawal N; Skelton AA; Saleena LM
    Mol Biosyst; 2016 Jul; 12(8):2519-31. PubMed ID: 27250644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative docking of dual conformations in human fatty acid synthase thioesterase domain reveals potential binding cavity for virtual screening of ligands.
    John A; Vetrivel U; Subramanian K; Deepa PR
    J Biomol Struct Dyn; 2017 May; 35(6):1350-1366. PubMed ID: 27145135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular docking studies of a group of hydroxamate inhibitors with gelatinase-A by molecular dynamics.
    Hou T; Zhang W; Xu X
    J Comput Aided Mol Des; 2002 Jan; 16(1):27-41. PubMed ID: 12197664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Gelatinases (MMP-2 and MMP-9) by Withania somnifera Phytochemicals Confers Neuroprotection in Stroke: An In Silico Analysis.
    Kumar G; Patnaik R
    Interdiscip Sci; 2018 Dec; 10(4):722-733. PubMed ID: 28488219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potent inhibitors against snake venom metalloproteinase (SVMP) using molecular docking and molecular dynamics studies.
    Chinnasamy S; Chinnasamy S; Nagamani S; Muthusamy K
    J Biomol Struct Dyn; 2015; 33(7):1516-27. PubMed ID: 25192471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular insights in repurposing selective COX-2 inhibitor celecoxib against matrix metalloproteinases in potentiating delayed wound healing: a molecular docking and MMPB/SA based analysis of molecular dynamic simulations.
    Mude L; Jupudi S; Swaroop AK; Tallapaneni V; Karri VVSR
    J Biomol Struct Dyn; 2024 Mar; 42(5):2437-2448. PubMed ID: 37160705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Employing comparative QSAR techniques for the recognition of dibenzofuran and dibenzothiophene derivatives toward MMP-12 inhibition.
    Tamang JSD; Banerjee S; Baidya SK; Ghosh B; Adhikari N; Jha T
    J Biomol Struct Dyn; 2024 Sep; 42(14):7304-7320. PubMed ID: 37498149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined spectroscopy and molecular modeling studies on the binding of galbanic acid and MMP9.
    Kiani A; Almasi K; Shokoohinia Y; Sadrjavadi K; Nowroozi A; Shahlaei M
    Int J Biol Macromol; 2015 Nov; 81():308-15. PubMed ID: 26253511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.